US Stock MarketDetailed Quotes
AUTL Autolus Therapeutics
- 2.600
- -0.080-2.99%
Close Jan 6 16:00 ET
- 2.511
- -0.090-3.44%
Post 20:01 ET
691.92MMarket Cap-2.13P/E (TTM)
2.700High2.570Low1.13MVolume2.690Open2.680Pre Close2.95MTurnover0.84%Turnover RatioLossP/E (Static)266.12MShares7.37052wk High1.45P/B349.63MFloat Cap2.07052wk Low--Dividend TTM134.47MShs Float53.240Historical High--Div YieldTTM4.85%Amplitude1.600Historical Low2.609Avg Price1Lot Size
Autolus Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -90.95%-76.74M | -33.91%-51.08M | 4.49%-40.51M | -29.63%-145.59M | -70.49%-24.83M | -25.97%-40.19M | -23.82%-38.15M | -21.09%-42.42M | 4.71%-112.31M | -59.05%-14.57M |
| Net income from continuing operations | -79.05%-82.09M | -27.92%-58.27M | -32.35%-52.69M | -40.01%-208.38M | -186.34%-77.17M | -7.20%-45.85M | -8.31%-45.55M | -7.42%-39.81M | -4.75%-148.84M | 35.32%-26.95M |
| Operating gains losses | -338.04%-14.09M | 83.73%-533K | 108.33%1.68M | -184.53%-3.81M | -20.46%-7.26M | 11.73%5.92M | ---3.28M | --804K | 571.28%4.51M | ---6.03M |
| Depreciation and amortization | 40.54%1.94M | 25.33%1.9M | -4.90%1.81M | -11.55%6.57M | 7.64%1.78M | -22.83%1.38M | -21.21%1.51M | -8.13%1.9M | -12.25%7.42M | -21.63%1.65M |
| Deferred tax | 29.41%-168K | 185.06%74K | -18.97%-232K | -267.91%-986K | -246.08%-466K | -48.75%-238K | 65.61%-87K | -12.07%-195K | -272.22%-268K | 175.95%319K |
| Other non cash items | 91.52%11.65M | 91.04%11.32M | 244.06%20.4M | 299.09%49.15M | 353.13%31.22M | 232.71%6.08M | 227.58%5.93M | 231.17%5.93M | 154.99%12.32M | 42.98%6.89M |
| Change In working capital | 118.66%2M | -1,434.88%-8.92M | -2.24%-13.75M | -45.52%292K | 287.64%23.8M | -775.90%-10.72M | 272.16%668K | -237.06%-13.45M | 30.73%536K | -66.23%6.14M |
| -Change in prepaid assets | 5.47%-4.79M | -254.40%-6.67M | -150.19%-10.11M | 223.62%13.36M | 86.92%18.14M | 52.56%-5.06M | 194.03%4.32M | 23.01%-4.04M | -262.45%-10.81M | -65.62%9.71M |
| -Change in payables and accrued expense | 1,797.13%8.27M | -182.09%-834K | 66.24%-2.46M | -96.95%489K | 1,019.47%7.24M | -105.08%-487K | -75.72%1.02M | -550.12%-7.28M | 517.75%16.03M | 110.90%647K |
| -Change in other current liabilities | 71.42%-1.48M | 69.65%-1.42M | 44.36%-1.18M | -189.20%-13.56M | ---1.59M | ---5.17M | ---4.67M | ---2.13M | -94.89%-4.69M | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -90.95%-76.74M | -33.91%-51.08M | 4.49%-40.51M | -29.63%-145.59M | -70.49%-24.83M | -25.97%-40.19M | -23.82%-38.15M | -21.09%-42.42M | 4.71%-112.31M | -59.05%-14.57M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -540.12%-9.59M | 80.84%-841K | 85.28%-533K | -1.34%-10.99M | -133.33%-1.48M | 77.96%-1.5M | -66.25%-4.39M | -369.78%-3.62M | -22.40%-10.84M | 60.06%-633K |
| Net PPE purchase and sale | -540.12%-9.59M | 80.84%-841K | 85.28%-533K | -1.34%-10.99M | -133.33%-1.48M | 77.96%-1.5M | -66.25%-4.39M | -369.78%-3.62M | -22.40%-10.84M | 60.06%-633K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -540.12%-9.59M | 80.84%-841K | 85.28%-533K | -1.34%-10.99M | -133.33%-1.48M | 77.96%-1.5M | -66.25%-4.39M | -369.78%-3.62M | -22.40%-10.84M | 60.06%-633K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 4,525.00%185K | -849.32%-2.08M | 81,350.51%561.44M | -100.39%-883K | -99.99%23K | -96.08%4K | -219K | -69,000.00%-691K | -21.28%223.61M | 51.62%223.51M |
| Net common stock issuance | --0 | --0 | --549.98M | --0 | --0 | --0 | --0 | --0 | -33.37%163.85M | ---- |
| Proceeds from stock option exercised by employees | 4,525.00%185K | --125K | --285K | -76.92%27K | --23K | --4K | --0 | --0 | -6.40%117K | --0 |
| Net other financing activities | --0 | -906.39%-2.2M | 1,717.80%11.18M | -101.53%-910K | --0 | --0 | ---219K | -69,000.00%-691K | 56.79%59.64M | --59.66M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 4,525.00%185K | -849.32%-2.08M | 81,350.51%561.44M | -100.39%-883K | -99.99%23K | -96.08%4K | ---219K | -69,000.00%-691K | -21.28%223.61M | 51.62%223.51M |
| Net cash flow | ||||||||||
| Beginning cash position | 129.66%706.96M | 121.21%759.54M | -37.21%240.34M | 23.20%382.76M | 57.22%256.85M | 42.01%307.83M | 27.69%343.36M | 23.20%382.76M | 101.63%310.68M | -5.71%163.37M |
| Current changes in cash | -106.67%-86.14M | -26.31%-54M | 1,213.57%520.39M | -256.73%-157.46M | -112.62%-26.29M | -7.99%-41.68M | -27.83%-42.76M | -30.53%-46.73M | -36.15%100.46M | 52.42%208.31M |
| Effect of exchange rate changes | 505.57%37.72M | -80.39%1.42M | -116.18%-1.19M | 152.97%15.03M | -11.82%9.77M | 37.13%-9.3M | 138.71%7.23M | 222.47%7.33M | -3,663.40%-28.38M | 1,409.95%11.08M |
| End cash Position | 156.39%658.54M | 129.66%706.96M | 121.21%759.54M | -37.21%240.34M | -37.21%240.34M | 57.22%256.85M | 42.01%307.83M | 27.69%343.36M | 23.20%382.76M | 23.20%382.76M |
| Free cash flow | -107.09%-86.33M | -22.07%-51.92M | 10.85%-41.05M | -27.14%-156.57M | -73.10%-26.31M | -7.71%-41.69M | -27.17%-42.54M | -28.60%-46.04M | 2.82%-123.15M | -41.48%-15.2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Price
% Chg
No Data